D. E. Shaw & Co., Inc. Stevanato Group S.P.A. Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 10,600 shares of STVN stock, worth $274,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,600
Previous 12,900
17.83%
Holding current value
$274,116
Previous $263,000
1.9%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding STVN
# of Institutions
138Shares Held
54.3MCall Options Held
0Put Options Held
0-
Conestoga Capital Advisors, LLC8.12MShares$210 Million2.96% of portfolio
-
Neuberger Berman Group LLC New York, NY4.47MShares$116 Million0.09% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.74MShares$96.6 Million0.06% of portfolio
-
Times Square Capital Management, LLC3.33MShares$86 Million1.25% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.28MShares$58.9 Million0.08% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $6.85B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...